Alkermes, Inc. (NASDAQ:ALKS)

Multiple Sclerosis Treatment Wins Big FDA Approval

Biogen Inc. (NASDAQ: BIIB) and Alkermes PLC (NASDAQ: ALKS) announced an update from the U.S. Food and Drug Administration on Wednesday morning. The FDA approved Vumerity for the treatment of ...
Read Full Story »

Alkermes Looks to Expand Its Schizophrenia Treatment to Bipolar Patients

Alkermes PLC (NASDAQ: ALKS) shares made a handy gain on Monday after the firm announced that it would be expanding its New Drug Application (NDA) for ALKS 3831 to encompass ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Amazon, American Water Works, Crocs, Deere, GE, Gilead, Slack, Teva and More

Stocks were indicated to open marginally higher on Monday, with the indexes effectively at all-time highs based on communication from Federal Reserve Chair Jerome Powell that the agency is expected ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alkermes, Apple, Canada Goose, FireEye, J.Jill, Kraft Heinz, Uber, Vonage and More

Stocks were indicated to open lower by over 250 points on the Dow Jones industrials and 30 points on the S&P 500 after President Trump announced a 5% tariff on ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alkermes, Alphabet, Apple, Conoco, FireEye, Lyft, McDonald’s, RBS, Seagate, Shopify and More

Stocks were indicated to open higher on the first day of trading in May, with the Dow Jones industrial average's 90-point gain being mostly driven by Apple's post-earnings surge. The ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Biogen, FedEx, Intel, Micron, Roku, Shake Shack and More

Stocks were in the middle of their worst December since the Great Depression, but Tuesday's small recovery was followed by some additional stock gains on Wednesday. The market is hoping ...
Read Full Story »

Why the FDA Is Dragging Alkermes Down

Alkermes PLC (NASDAQ: ALKS) shares dropped 8% early on Friday in premarket trading after the company announced the results from its most recent meeting with the U.S. Food and Drug ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts, Zillow and More

Stocks were indicated to higher on Tuesday after Monday's recovery rally. Investors have seen a very strong earnings season, with 80% of the S&P 500 reporting earnings and over 70% ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alkermes, Cigna, International Paper, Medtronic, Tesla, Western Digital and More

The futures traded higher again Wednesday morning, perhaps in part because of the fact that the Russell 2000 hit an all-time high on Tuesday. That is a move that no ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp, Sarepta Therapeutics and More

The futures traded just a touch higher Friday morning as the market continued to digest some big gains from the past two weeks. Stocks took off once again yesterday when ...
Read Full Story »

Alkermes Wins Big on FDA Approval

Shares of Alkermes PLC (NASDAQ: ALKS) saw a handy gain to start out the week after the U.S. Food and Drug Administration (FDA) made a critical decision. Specifically, the FDA ...
Read Full Story »

FDA Gets Down on Alkermes Depression Drug

Alkermes PLC (NASDAQ: ALKS) saw its shares drop early on Monday after the company announced that it received a letter from the U.S. Food and Drug Administration (FDA). Specifically, the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alkermes, ArQule, Bluebird Bio, Cognizant, Ecolab, KLA-Tencor, Pandora, Verisk, Vonage and More

The stock market has demonstrated that perhaps the return of volatility is real after Wednesday's big gains suddenly turned into a big loss in the final 30 minutes of trading. ...
Read Full Story »

20 More Biopharma Catalysts Coming in 2018

Over the course of 2017, biopharmaceutical companies more or less kept pace with the markets, ending up with a return just a little higher than the S&P 500. But going in ...
Read Full Story »

Alkermes Could Win Big With New Biogen Partnership

Alkermes PLC (NASDAQ: ALKS) shares made a handy gain to start the week, after the firm announced that it has entered into a global license agreement with Biogen Inc. (NASDAQ: ...
Read Full Story »